Home Cart 0 Sign in  
X

[ CAS No. 2835-99-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 2835-99-6
Chemical Structure| 2835-99-6
Chemical Structure| 2835-99-6
Structure of 2835-99-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 2835-99-6 ]

Related Doc. of [ 2835-99-6 ]

Alternatived Products of [ 2835-99-6 ]

Product Details of [ 2835-99-6 ]

CAS No. :2835-99-6 MDL No. :MFCD00007871
Formula : C7H9NO Boiling Point : -
Linear Structure Formula :- InChI Key :QGNGOGOOPUYKMC-UHFFFAOYSA-N
M.W : 123.15 Pubchem ID :17819
Synonyms :

Calculated chemistry of [ 2835-99-6 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.14
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 2.0
Molar Refractivity : 37.84
TPSA : 46.25 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.41 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.19
Log Po/w (XLOGP3) : 0.9
Log Po/w (WLOGP) : 1.29
Log Po/w (MLOGP) : 1.15
Log Po/w (SILICOS-IT) : 1.11
Consensus Log Po/w : 1.13

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.66
Solubility : 2.67 mg/ml ; 0.0217 mol/l
Class : Very soluble
Log S (Ali) : -1.46
Solubility : 4.31 mg/ml ; 0.035 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.8
Solubility : 1.93 mg/ml ; 0.0157 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 2835-99-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 2835-99-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 2835-99-6 ]
  • Downstream synthetic route of [ 2835-99-6 ]

[ 2835-99-6 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 543-87-3 ]
  • [ 2835-99-6 ]
  • [ 144-55-8 ]
  • [ 15579-15-4 ]
Reference: [1] Patent: EP1256574, 2002, A1,
  • 2
  • [ 2835-99-6 ]
  • [ 15579-15-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2007, vol. 15, # 1, p. 350 - 364
  • 3
  • [ 611-22-3 ]
  • [ 2835-99-6 ]
  • [ 95-53-4 ]
  • [ 87-63-8 ]
  • [ 95-69-2 ]
Reference: [1] Canadian Journal of Chemistry, 1996, vol. 74, # 7, p. 1321 - 1328
  • 4
  • [ 2835-99-6 ]
  • [ 452-70-0 ]
Reference: [1] Tetrahedron, 1996, vol. 52, # 1, p. 23 - 36
[2] Journal of Fluorine Chemistry, 1991, vol. 51, # 2, p. 299 - 304
  • 5
  • [ 2835-99-6 ]
  • [ 133921-27-4 ]
YieldReaction ConditionsOperation in experiment
47%
Stage #1: With hydrogenchloride; sodium nitrite In tetrahydrofuran; water at 0℃;
Stage #2: With potassium iodide In tetrahydrofuran; water at 0℃; for 0.25 h;
Example 25: Synthesis of(E)-4-((2-(4-((Z)-l-(4-hydroxyphenyl)-2-phenylbut-l-en-l-yl)-3- methylphenoxy)ethyl)amino)-N,N-dimethylbut-2-enamide Step-1: Synthesis of 4-iodo-3-methylphenol 3 M HCI/ J To a solution of 4-amino-3-methylphenol (10 g, 81 mmol) in THF (45 mL) was added 3M HC1 (35 mL) at 0 °C over a period of 10 min followed by NaN02 (6.1 g, 89 mmol). To the above reaction mixture, potassium iodide (53.89 g, 166 mmol) in water (140 mL) was added dropwise and stirred at 0 °C for 15 min. After completion of reaction, reaction mixture was extracted with EtOAc. Organic layer was washed water followed by brine, concentared under reduced pressure to obtain the crude compound. Crude material was purified by column chromatography over 230-400 mesh silica gel using 10percent EtOAc in n-hexane to give the title compound (9 g, 47percent).
15%
Stage #1: With sulfuric acid; sodium nitrite In water at 0℃; for 0.333333 h;
Stage #2: With copper(l) iodide; sulfuric acid; potassium iodide In water at 0℃; for 3 h; Heating / reflux
15 g (122 mol) of 4-hydroxy-2-methylaniline are dissolved in 180 ml of 20percent sulphuric acid and then the reaction medium is cooled to 0° C. A solution of sodium nitrite (11.3 g, 163 mmol) in 60 ml of water is then added dropwise and then the medium is stirred for 20 minutes. This solution is then slowly added to a solution at 0° C. of CuI (32.5 g, 170 mmol) and KI (31.9 g, 193 mmol) in 180 ml of 20percent sulphuric acid. The reaction medium is heated under reflux for 3 hours, poured into 1 l of water and extracted with ethyl ether. The organic phases are washed with a saturated sodium thiosulphate solution, of water, dried over magnesium sulphate and concentrated under reduced pressure. After purification on a silica column (ethyl acetate 30-heptane 70), a brown oil is obtained (m 4.2 g; Y=15percent).
Reference: [1] Patent: WO2016/196342, 2016, A1, . Location in patent: Page/Page column 129
[2] Patent: US6689922, 2004, B1, . Location in patent: Page column 85
[3] Journal of the Chemical Society, 1951, p. 1184,1186
[4] Patent: US6562823, 2003, B1,
Same Skeleton Products
Historical Records